Interní Med. 2013; 15(2): 78-79

Clinical experience with a fixed combination of candesartan 32 mg and hydrochlorothiazide

MUDr.Jiří Slíva, Ph.D.
Ústavy farmakologie 2. a 3. lékařská fakulta UK, Praha

Currently, hypertension is one of the most common disease affecting cardiovascular system. Even if the monotherapy by antihypertensives

is used, many patients are not controlled adequately, thus combination treatment has to be started. This article summarizes up to

date clinical experience with candesartan in a combination with a thiazide diuretic agent, hydrochlorothiazide.

Keywords: hypertension, sartans, candesartan, diuretics, hydrochlorothiazide

Published: March 8, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Slíva J. Clinical experience with a fixed combination of candesartan 32 mg and hydrochlorothiazide. Interní Med. 2013;15(2):78-79.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Oparil S. Newly emerging pharmacologic differences in angiotensin II receptor blockers. Am.J.Hypertens. 2000; 13: 18S-24S. Go to original source... Go to PubMed...
    2. Fuchs B, Breithaupt-Grogler K, Belz GG, et al. Comparative pharmacodynamics and pharmacokinetics of candesartan and losartan in man. J.Pharm.Pharmacol 2000; 52: 1075-1083. Go to original source... Go to PubMed...
    3. Easthope SE, Jarvis B. Candesartan cilexetil: an update of its use in essential hypertension. Drugs 2002; 62: 1253-1287. Go to original source... Go to PubMed...
    4. Lacourciere Y, Asmar R. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators. Am.J.Hypertens. 1999; 12: 1181-1187. Go to original source... Go to PubMed...
    5. Slíva J, Votava M. Farmakologie, Lékařské repetitorium Edition, Praha: Triton, 2011: 400 pp.
    6. Bonner G. Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy. Blood Press Suppl 2008; 2: 22-30. Go to original source... Go to PubMed...
    7. Edes I. Combination therapy with candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg provides the full additive antihypertensive effect of the components: A randomized, double-blind, parallel-group study in primary care. Clin Drug Investig. 2009; 29: 293-304. Go to original source... Go to PubMed...
    8. Bonner G, Landers B, Bramlage P. Candesartan cilexetil/ hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T). Vasc. Health Risk Manag. 2011; 7: 85-95. Go to original source... Go to PubMed...
    9. Lee HY, Hong BK, Chung WJ, et al. Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension. Clin Ther. 2011; 33: 1043-1056. Go to original source... Go to PubMed...
    10. Mengden T, Vetter H, Tousset E, Uen S. Management of patients with uncontrolled arterial hypertension-the role of electronic compliance monitoring, 24-h ambulatory blood pressure monitoring and Candesartan/HCTZ. BMC.Cardiovasc.Disord. 2006; 6: 36. Go to original source... Go to PubMed...
    11. Slíva J. Candesartan v léčbě kardiovaskulárních onemocnění. Farmakoterapie 2012; 8: 53-57.
    12. Granger BB, Swedberg K, Ekman I, et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 2005; 366: 2005-2011. Go to original source... Go to PubMed...
    13. Mugellini A, Nieswandt V. Candesartan plus hydrochlorothiazide: an overview of its use and efficacy. Expert.Opin. Pharmacother. 2012; 13: 2699-2709. Go to original source... Go to PubMed...
    14. Aberg JG, Olofsson B, Karlson BW. Pharmacokinetic interaction study with fixed high dose combinations of candesartan cilexetil and hydrochlorothiazide. Int.J.Clin Pharmacol Ther. 2011; 49: 750-755. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.